Amgen, the World's Biggest Biotechnology Group: The Competitive Strategies


Code : COM0110

Year :

Industry : Health Care

Region : USA

Teaching Note: Available

Structured Assignment : Available

Buy This Case Study

Abstract: Since its inception in 1980 as Applied Molecular Genetics Incorporated, Amgen's growth to become the world's largest biotechnology company with sales of $12.4 billion in 2005 has been phenomenal. Through its innovations, acquisition of companies like Immunex and other operational strategies, Amgen has avoided the dual menace of sluggish growth and stiff competition that has hit many pharmaceutical and biotechnological behemoths.

Pedagogical Objectives:

  • To highlight the strategies adopted by Amgen to become the biggest biotechnology company in the world in a relatively short span of 25 years
  • To focus on the global biotechnology industry and the competitive landscape of Amgen
  • To discuss the competitive strategies adopted by Amgen to retain its leadership.

  • For Case Books Click Here >>

    For Case eBooks Click Here >>

    Keywords : Global biotechnology industry; Acquisition of Immunex; Blockbuster biopharmaceuticals and drugs; Strategic acquisitions of Amgen; Competitive Strategies Case Study; Patents of Amgen; Biotechnology drug development process; Amgen's acquisitions and partnerships; Research and development expenditure of Amgen; Eranasp; Neupogen, Enbrel, Epogen; Molecular biology

    Contents :
    Amgen: The Making of the Biotechnology Behemoth
    The Competitive Landscape, Competitors and Competitive Strategies
    Amgen's Strategies to Maintain its Leadership

    Case Introduction >>

    Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
    Mob: +91- 9640901313,

    2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap